PRTN3 and rheumatoid arthritis: Early RA with diagnosed<1 year, or high-risk individuals with inflammatory arthralgia and elevated RF and/or ACPA levels; healthy controls without autoimmune conditions; all participators age≥18 years, and had a minimum of 12 natural teeth